Insiders At Evolus Sold US$5.6m In Stock, Alluding To Potential Weakness

Simply Wall StNov 12 09:31 ET

Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Yahoo FinanceNov 9 09:23 ET

Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating

Moomoo NewsNov 8 08:32 ET · Ratings

A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $20 to $27

Moomoo NewsNov 8 08:00 ET · Ratings

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Poseida Therapeutics (PSTX) and Evolus (EOLS)

TipRanksNov 8 07:30 ET · Ratings

Evolus Down Over 11%, on Pace for Largest Percent Decrease Since August 2022 -- Data Talk

Dow JonesNov 7 12:55 ET